Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Cell Trials Data is not an online course platform in the conventional sense. It is a specialist data-product website for the advanced cell therapy and gene therapy sectors. Its main business is selling searchable and sortable Excel datasets, while also offering consulting services and custom data. Its products cover topics such as exosome/extracellular vesicle clinical trials, MSC trials, in vivo gene therapy trials, cell and gene therapy CMO/CDMO facilities, cord blood banks, and more.
In terms of subject area, it is highly focused on frontier life-science fields, especially clinical trial intelligence for cell therapy, gene therapy, EV/secretome, MSC, CAR-T, and related areas. As for delivery format, the site does not show live classes, recorded courses, or 1v1 instruction. The deliverables are mainly Excel databases, making it better suited as a research resource or business intelligence tool rather than a learning course. No accreditation or certificates are disclosed. The website and field descriptions are in English, so users need both professional English ability and a biomedical background.
The team and institutional background are relatively strong. CellTrials.org is part of Parent's Guide to Cord Blood Foundation. The team includes Alexey Bersenev, MD PhD, associated with the Yale University Cell Therapy Laboratory, as well as researchers such as Frances Verter, PhD and Pedro Silva Couto, PhD. The website emphasizes manual searches across multiple international registries and the organization of roughly 19-22 parameters for each trial.
The pricing is positioned more toward B2B users and research institutions. The exosome clinical trials database costs $1,550, the gene therapy trials database costs $900, the CMO/CDMO database costs $700, and some MSC datasets are priced at $750-$1,250. There are also free COVID-19 data and academic datasets. For competitor research, trial planning, investment analysis, or supplier lead screening, the value in reducing manual search costs is fairly clear; however, the price is high for individual learners.
Its strengths are its vertical focus, professional depth, clear data fields, and coverage of international registry sources beyond ClinicalTrials.gov. The text specifically notes that it can help supplement trial data from regions such as China. Its weaknesses are the lack of a course structure, explanatory videos, learning paths, certificates, and clearly stated after-sales support. Non-specialist users will face a relatively high barrier to use.
It is suitable for BD, marketing, and R&D teams at biopharma companies, clinical trial planners, investment analysts, suppliers, and academic researchers. It is not suitable for learners looking for beginner-friendly teaching, career certificates, or interactive training.
The crawled text does not specify access stability from mainland China or payment methods, so China access is rated as unknown, and payment information is also insufficient. Before actual use, it is advisable to open a sample file first to test downloading and the payment process. Alternatives include ClinicalTrials.gov, WHO ICTRP, Cell and Gene Therapy Catapult, the J Gene Therapy database, and relevant review papers, but these alternatives usually require more manual cleaning and integration.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on celltrials.net official site.
celltrials.net is an Unknown Education provider. TG4G tracks its product information, with monthly pricing from $1,550.00, an overall rating of 7.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach celltrials.net directly.